Korean J Hematol.  2011 Mar;46(1):6-8. 10.5045/kjh.2011.46.1.6.

Health insurance system for hematologic diseases: what should we do?

• Jang MJ
• Park HJ
• Yoon SS
• Lee JH
• Park KD
• Kim SJ
• Im HJ
• Kim JS
• Jang JH
• Oh SJ
• Cho HS
• Song JW
• Lim YJ
• Kim HY

• KMID: 2252010
• DOI: http://doi.org/10.5045/kjh.2011.46.1.6

Abstract

No abstract available.

MeSH Terms

Insurance, Health

Figure

• 

  Fig. 1 Increase of drug cost.

Reference

1. Kim KS, Lee YJ. Developments and general features of national health insurance in Korea. Soc Work Public Health. 2010; 25:142–157. PMID: 20391258.

2. Ministry of Health and Welfare. Drug cost containment in health insurance. 2006. Seoul, Korea: Ministry of Health and Welfare.

3. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010; 25:1113–1121. PMID: 20676319.

4. Tchoe B, Nam SH. Aging risk and health care expenditure in Korea. Int J Environ Res Public Health. 2010; 7:3235–3254. PMID: 20948958.

5. The Korea Institute for Health and Social Affairs. A Report of Korea Health Panel Survey. 2008. Seoul, Korea: The National Health Insurance Corporation.